Evidence map›Paper›PMID 30673776›Full record

ArticlePloS one2019

Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.

Olivier Ballo, Ikram Tarazzit, Jan Stratmann, Claudia Reinheimer, Michael Hogardt, Thomas A Wichelhaus, Volkhard Kempf, Hubert Serve, Fabian Finkelmeier, Christian Brandts

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Multidrug-Resistant Bacteria in Immunocompromised Patients.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Fever of Unknown Origin and Multidrug Resistant Organism Colonization in AML Patients.Mediterranean journal of hematology and infectious diseases · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Olivier BalloDepartment of Medicine, Hematology/Oncology, Goethe University Hospital, Frankfurt/Main, Germany.ORCID 0000-0003-1634-1988
Ikram TarazzitDepartment of Medicine, Hematology/Oncology, Goethe University Hospital, Frankfurt/Main, Germany.
Jan StratmannDepartment of Medicine, Hematology/Oncology, Goethe University Hospital, Frankfurt/Main, Germany.ORCID 0000-0001-7726-6622
Claudia ReinheimerInstitute of Medical Microbiology and Infection Control, Goethe University Hospital, Frankfurt/Main, Germany.
Michael HogardtInstitute of Medical Microbiology and Infection Control, Goethe University Hospital, Frankfurt/Main, Germany.
Thomas A WichelhausInstitute of Medical Microbiology and Infection Control, Goethe University Hospital, Frankfurt/Main, Germany.
Volkhard KempfInstitute of Medical Microbiology and Infection Control, Goethe University Hospital, Frankfurt/Main, Germany.
Hubert ServeDepartment of Medicine, Hematology/Oncology, Goethe University Hospital, Frankfurt/Main, Germany.
Fabian FinkelmeierUniversity Cancer Center Frankfurt (UCT), Goethe University Hospital, Frankfurt/Main, Germany.
Christian BrandtsDepartment of Medicine, Hematology/Oncology, Goethe University Hospital, Frankfurt/Main, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe global spread of multidrug-resistant organisms (MDRO) complicates treatment and isolation measures in hospitals and has shown to increase mortality. Patients with disease- or therapy-related immunodeficiency are especially at risk for fatal infections caused by MDRO. The impact of MDRO colonization on the clinical course of AML patients undergoing intensive induction chemotherapy-a potentially curative but highly toxic treatment option-has not been systematically studied. MATERIALS &

methods312 AML patients undergoing intensive induction chemotherapy between 2007 and 2015 were examined for MDRO colonization. Patients with evidence for MDRO before or during the hospital stay of induction chemotherapy were defined as colonized, patients who never had a positive swab for MDRO were defined as noncolonized.

resultsOf 312 AML patients 90 were colonized and 130 were noncolonized. Colonized patients suffered from significantly more days with fever, spent more days on the intensive care unit and had a higher median C-reactive protein value during the hospital stay. These findings did not result in a prolonged length of hospital stay or an increased mortality rate for colonized patients. However, in a subgroup analysis, patients colonized with carbapenem-resistant enterobacteriaceae (CRE) had a significantly reduced 60- and 90-day, as well as 1- and 2-year survival rates when compared to noncolonized patients.

conclusionOur analysis highlights the importance of intensive MDRO screening especially in patients with febrile neutropenia since persisting fever can be a sign of MDRO-colonization. CRE-colonized patients require special surveillance, since they seem to be at risk for death.

Indexed as

Drug Resistance, Multiple, BacterialInduction ChemotherapyAdolescentAdultAgedAged, 80 and overBacterial InfectionsFemaleGram-Negative Bacterial InfectionsGram-Positive Bacterial InfectionsHumansIntensive Care UnitsKaplan-Meier EstimateLeukemia, Myeloid, AcuteMaleMethicillin-Resistant Staphylococcus aureus

Identifiers

PMID30673776
PMCPMC6343922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.